Back to search

Article

AIM2 is a novel biomarker for predicting prognosis and immunotherapy response of clear cell renal cell carcinoma

2023-04-03

Abstract excerpt

<h4>Background: </h4> As an indispensable component of the inflammasome, absent in melanoma 2 (AIM2) plays an essential role in the initiation of the innate immune response, while its effects on clear cell renal cell carcinoma (ccRCC) still remain unclear. In this research, we aimed to evaluate the predictive value of AIM2 on prognosis and immunotherapy effects in patients suffering from ccRCC. Methods In this st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b165e4b8-3489-57a3-9881-8242e3683ee3
DOI
10.21203/rs.3.rs-2756658/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
AIM2 is a novel biomarker for predicting prognosis and immunotherapy response of clear cell renal cell carcinomaDOI 10.21203/rs.3.rs-2756658/v1
N6-methyladenosine Methylation Related Immune Biomarkers Correlates With Clinicopathological Characteristics and Prognosis in Clear Cell Renal Cell CarcinomaSemantic proximity
AIM2 is an potential biomarker associated with the Immune-active Tumor Microenvironment Remodeling and PANoptosis in skin cutaneous melanomaSemantic proximity
The complex role of AIM2 in autoimmune diseases and cancersSemantic proximity
The role of AIM2 in inflammation and tumorsSemantic proximity
CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer TypesSemantic proximity
RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell CarcinomaSemantic proximity
Based on the identification of tumor antigens and immune subtypes in renal clear cell carcinoma for mRNA vaccine developmentSemantic proximity
A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironmentSemantic proximity
Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinomaSemantic proximity
Upregulation of ARNTL2 Predicts Poor Survival for Clear Cell Renal Cell Carcinoma and Explores its Associations with PD-L1 and Immune InfiltrationSemantic proximity
The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinomaSemantic proximity
Development of a SETD2-related immune prognostic signature in clear cell renal cell carcinoma.Semantic proximity
Select a neighboring publication to make it the new centre.